Article
XRCC1 genetic polymorphism acts a potential biomarker for lung cancer.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine - 1 May 2015
Zhu Dao-Qi, Zou Qiong, Hu Chun-Hong, Su Jia-Li, Zhou Guang-Hua, Liu Ping
Abstract excerpt
Lung cancer is one of the most common but serious cancers in the world. Both the X-ray repair cross-complementing group 1 (XRCC1) gene and the human multidrug resistance 1 (MDR1) gene are important candidate genes influencing the susceptibility to various diseases, including lung cancer. This study aimed to assess the correlation of genetic polymorphisms in XRCC1 and MDR1 with the susceptibility to lung cancer....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
